Total Payments
$853.74
2024 Payments
$121.98
Companies
17
Transactions
49
Medicare Patients
2,099
Medicare Billing
$179,074
Payment Breakdown by Category
Food & Beverage$853.74 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $853.74 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $255.16 | 19 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $121.98 | 1 | $0 (2024) |
| Amgen Inc. | $79.67 | 5 | $0 (2021) |
| Amarin Pharma Inc. | $70.37 | 5 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $45.00 | 2 | $0 (2021) |
| Lundbeck LLC | $41.58 | 2 | $0 (2021) |
| PFIZER INC. | $33.47 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $33.18 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $27.88 | 2 | $0 (2021) |
| Althera Pharmaceuticals LLC | $24.19 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.98 | 1 | Otsuka America Pharmaceutical, Inc. ($121.98) |
| 2023 | $34.85 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($18.82) |
| 2021 | $359.18 | 23 | Janssen Pharmaceuticals, Inc ($54.19) |
| 2020 | $116.93 | 8 | Janssen Pharmaceuticals, Inc ($39.64) |
| 2019 | $77.15 | 4 | Janssen Pharmaceuticals, Inc ($32.20) |
| 2018 | $67.05 | 5 | Janssen Pharmaceuticals, Inc ($67.05) |
| 2017 | $76.60 | 6 | Janssen Pharmaceuticals, Inc ($62.08) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $121.98 | General |
| 05/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardio-renal | ||||||
| 01/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 11/02/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Cardiovascular | ||||||
| 10/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiovascular | ||||||
| 06/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/27/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2021 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| Category: NEUROLOGY | ||||||
| 05/13/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: Cardiovascular | ||||||
| 05/04/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 04/29/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiology | ||||||
| 04/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: DIABETES | ||||||
| 04/12/2021 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| Category: NEUROLOGY | ||||||
| 04/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/07/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiology | ||||||
| 03/18/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.51 | General |
| Category: Cardiovascular | ||||||
| 03/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular | ||||||
| 02/25/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiology | ||||||
| 02/23/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Cardiovascular | ||||||
| 02/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardiovascular | ||||||
| 02/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 176 | 202 | $89,755 | $21,712 |
| 2022 | 5 | 267 | 299 | $143,095 | $31,957 |
| 2021 | 12 | 627 | 752 | $126,925 | $44,999 |
| 2020 | 14 | 1,029 | 1,285 | $275,605 | $80,406 |
Total Patients
2,099
Total Services
2,538
Medicare Billing
$179,074
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 68 | 71 | $43,452 | $9,954 | 22.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 37 | 49 | $24,353 | $5,921 | 24.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 22 | 32 | $10,720 | $2,690 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 17 | $2,856 | $1,483 | 51.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 14 | 14 | $6,664 | $1,471 | 22.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $1,710 | $192.80 | 11.3% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 81 | 82 | $48,009 | $10,681 | 22.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 65 | 95 | $44,959 | $9,947 | 22.1% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 84 | 84 | $38,075 | $8,619 | 22.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 23 | 24 | $7,656 | $1,725 | 22.5% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 14 | 14 | $4,396 | $986.06 | 22.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 47 | $16,026 | $7,922 | 49.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 47 | 88 | $18,552 | $7,645 | 41.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 59 | 97 | $14,763 | $5,920 | 40.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 48 | 48 | $13,635 | $5,482 | 40.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 21 | 21 | $9,555 | $3,524 | 36.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 38 | $6,270 | $3,524 | 56.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 38 | 38 | $5,737 | $2,226 | 38.8% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2021 | 32 | 32 | $8,166 | $2,106 | 25.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 161 | 188 | $11,046 | $1,308 | 11.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $2,805 | $1,289 | 46.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,935 | $1,271 | 43.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 14 | $2,310 | $1,198 | 51.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 47 | 58 | $4,640 | $653.16 | 14.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 30 | 30 | $4,464 | $558.60 | 12.5% |
About Dr. George Moutsatsos, M.D
Dr. George Moutsatsos, M.D is a Cardiovascular Disease healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609843309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Moutsatsos, M.D has received a total of $853.74 in payments from pharmaceutical and medical device companies, with $121.98 received in 2024. These payments were reported across 49 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($853.74).
As a Medicare-enrolled provider, Moutsatsos has provided services to 2,099 Medicare beneficiaries, totaling 2,538 services with total Medicare billing of $179,074. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Meadowbrook, PA
- Active Since 03/02/2006
- Last Updated 02/18/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1609843309
Products in Payments
- XARELTO (Drug) $255.16
- Repatha (Biological) $79.67
- ELIQUIS (Drug) $78.47
- Vascepa (Drug) $70.37
- NORTHERA (Drug) $41.58
- BRILINTA (Drug) $33.18
- ENTRESTO (Drug) $27.88
- Roszet (Drug) $24.19
- ZIO Patch (Device) $23.33
- PRALUENT (Drug) $21.62
- Kerendia (Drug) $18.82
- LEXISCAN (Drug) $16.30
- Rybelsus (Drug) $16.03
- JARDIANCE (Drug) $12.85
- Livalo (Drug) $12.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Meadowbrook
Thomas Santilli, Md, MD
Cardiovascular Disease — Payments: $25,074
Cardiovascular Disease $25,074
Kevin Lax, Md, MD
Cardiovascular Disease — Payments: $16,106
Cardiovascular Disease $16,106
Andrew Mustin, Md, MD
Cardiovascular Disease — Payments: $12,375
Cardiovascular Disease $12,375
John Green
Cardiovascular Disease — Payments: $11,265
Cardiovascular Disease $11,265
Peter Shaftel, Md, MD
Cardiovascular Disease — Payments: $10,251
Cardiovascular Disease $10,251
Dr. Bradford Lin, M.d, M.D
Cardiovascular Disease — Payments: $31.30
Cardiovascular Disease $31.30